中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共7条，第1-7条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Efficacy of everolimus-containing chemotherapy in HER2 negative metastatic breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Wang, Rong;  Wang, Xiaojia;  Chen, Zhan-Hong;  Niu, Jin;  Huang, Yuan;  Pan, Jiani;  Ye, Weiwu;  Cao, Wenming
收藏  |  浏览/下载：65/0  |  提交时间：2022/01/10
Pyrotinib plus capecitabine for HER2-positive metastatic breast cancer patients with brain metastases (PERMEATE): A multicenter, single-arm phase II study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Yan, Min;  Ouyang, Quchang;  Sun, Tao;  Niu, Limin;  Yang, Jin;  Li, Li;  Song, Yuhua;  Hao, Chunfang;  Chen, Zhanhong
收藏  |  浏览/下载：41/0  |  提交时间：2022/01/10
Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Shao, Xiying;  Zheng, Yabing;  Cao, Wenming;  Shen, Xiabo;  Li, Guangliang;  Chen, Junqing;  Huang, Yuan;  Huang, Ping;  Shi, Lei;  Ye, Weiwu;  Zou, Weibin;  Lou, Caijin;  Lei, Lei;  Huang, Jian;  Chen, Zhanhong;  Wang, Xiaojia
收藏  |  浏览/下载：47/0  |  提交时间：2021/06/15
Ki67  progesterone receptor  palbociclib  
Exploring the concepts and practices of advanced breast cancer treatment: a narrative review 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Wang, Xiaojia;  Shao, Xiying;  Huang, Jian;  Lei, Lei;  Huang, Yuan;  Zheng, Yabing;  Cao, Wenming;  Chen, Zhanhong
收藏  |  浏览/下载：50/0  |  提交时间：2021/06/15
Metastatic breast cancer (MBC)  treatment  cure  molecular types  targeted therapy  
Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2-Breast Cancer Patient With High Tumor Mutational Burden 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 10
作者:  Wang, Rong;  Yang, Yuchen;  Ye, Wei-Wu;  Xiang, Jianxing;  Chen, Songan;  Zou, Wei-Bin;  Wang, Xiao-Jia;  Chen, Tianhui;  Cao, Wen-Ming
收藏  |  浏览/下载：53/0  |  提交时间：2021/04/26
breast cancer  immunotherapy  biomarker  TMB  NGS  molecular monitoring  
Primary analysis of OVERSTEP: A multicenter, randomized clinical trial of capecitabine or endocrine therapy as a maintenance therapy after the 1st-line chemotherapy in hormone receptor positive and HER2-negative advanced/metastatic breast cancer 期刊论文
CANCER RESEARCH, 2021, 卷号: 81
作者:  Huang, Jian;  Shao, Xiying;  Cai, Li;  Shi, Yanxia;  Chen, Zhanhong;  Huang, Ping;  Yin, Yongmei;  Zhang, Lili;  Shen, Peng;  Cao, Wenming;  Ye, Weiwu;  Huang, Yuan;  Lou, Caijin;  Lei, Lei;  Zheng, Yabin;  Zou, Weibin;  Chen, Junqing;  Wang, Xiaojia
收藏  |  浏览/下载：47/0  |  提交时间：2021/04/26
The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Tian, Yiping;  Sun, Xiaohui;  Cheng, Guoping;  Ji, Enming;  Yang, Shifeng;  Feng, Jianguo;  Zheng, Linfeng
收藏  |  浏览/下载：56/0  |  提交时间：2021/05/17
CMTM6  PD-L1  triple-negative breast cancer (TNBC)  immunohistochemistry (IHC)  polymerase chain reaction (PCR)  prognosis